Review paper: Cancer chemopreventive compounds and canine cancer.

作者: S. J. Baek , M. F. Mcentee , A. M. Legendre

DOI: 10.1354/VP.08-VP-0238-B-REV

关键词: NonsteroidalLife expectancyShared environmentMolecular targetsPharmacologyMedicineChemoprophylaxisCancerBioinformaticsCanine cancerDisease

摘要: Canine cancer has become more prevalent in recent years because of increased life expectancy and greater attention to the health pets. The range cancers seen dogs is as diverse that human patients, despite intensive therapeutic interventions, fatality rates remain unacceptably high both species. Chemoprevention therefore an important means confronting this disease. Because domestic pets share our environment, cross-application study protumorigenic antitumorigenic factors shared environment will benefit all species, leading development new families less toxic compounds based on novel established molecular targets. Currently, most interesting preventive agents are nonsteroidal anti-inflammatory drugs, peroxisome proliferator-activated receptor-gamma ligands, dietary compounds. This article provides overview what known about how these affect signaling neoplastic disease, with reference reported application and/or where available.

参考文章(123)
Vin Tangpricha, Catherine Spina, Min Yao, Tai C. Chen, M. Michael Wolfe, Michael F. Holick, Vitamin D Deficiency Enhances the Growth of MC-26 Colon Cancer Xenografts in Balb/c Mice Journal of Nutrition. ,vol. 135, pp. 2350- 2354 ,(2005) , 10.1093/JN/135.10.2350
Elizabeth G. Sonnenschein, Lowrence T. Glickman, Michael H. Goldschmidt, Linda J. McKee, Body conformation, diet, and risk of breast cancer in pet dogs: a case-control study. American Journal of Epidemiology. ,vol. 133, pp. 694- 703 ,(1991) , 10.1093/OXFORDJOURNALS.AJE.A115944
William C. Kisseberth, Charles C. Capen, Thattawan Kaewsakhorn, Nongnuch Inpanbutr, Kathleen A. Hayes, Martin J. Calverley, Effects of calcitriol, seocalcitol, and medium-chain triglyceride on a canine transitional cell carcinoma cell line. Anticancer Research. ,vol. 25, pp. 2689- 2696 ,(2005)
John J. Nolan, Bernhard Ludvik, Patricia Beerdsen, Mary Joyce, Jerrold Olefsky, Improvement in Glucose Tolerance and Insulin Resistance in Obese Subjects Treated with Troglitazone New England Journal of Medicine. ,vol. 331, pp. 1188- 1193 ,(1994) , 10.1056/NEJM199411033311803
Gideon Steinbach, Patrick M. Lynch, Robin K.S. Phillips, Marina H. Wallace, Ernest Hawk, Gary B. Gordon, Naoki Wakabayashi, Brian Saunders, Yu Shen, Takashi Fujimura, Li-Kuo Su, Bernard Levin, Louis Godio, Sherri Patterson, Miguel A. Rodriguez-Bigas, Susan L. Jester, Karen L. King, Marta Schumacher, James Abbruzzese, Raymond N. DuBois, Walter N. Hittelman, Stuart Zimmerman, Jeffrey W. Sherman, Gary Kelloff, The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous Polyposis The New England Journal of Medicine. ,vol. 342, pp. 1946- 1952 ,(2000) , 10.1056/NEJM200006293422603
Francis M. Giardiello, Stanley R. Hamilton, Anne J. Krush, Steven Piantadosi, Linda M. Hylind, Paul Celano, Susan V. Booker, C. Rahj Robinson, G. Johan A. Offerhaus, Treatment of Colonic and Rectal Adenomas with Sulindac in Familial Adenomatous Polyposis New England Journal of Medicine. ,vol. 328, pp. 1313- 1316 ,(1993) , 10.1056/NEJM199305063281805
Seung Joon Baek, Kyung-Su Kim, Jennifer B. Nixon, Leigh C. Wilson, Thomas E. Eling, Cyclooxygenase Inhibitors Regulate the Expression of a TGF-β Superfamily Member That Has Proapoptotic and Antitumorigenic Activities Molecular Pharmacology. ,vol. 59, pp. 901- 908 ,(2001) , 10.1124/MOL.59.4.901
Richard M. Breyer, Prostaglandin EP1 Receptor Subtype Selectivity Takes Shape Molecular Pharmacology. ,vol. 59, pp. 1357- 1359 ,(2001) , 10.1124/MOL.59.6.1357
Sunee Kunakornsawat, Thomas J. Rosol, Steven S. Hannah, Charles C. Capen, Rondo P. Middleton, Nongnuch Inpanbutr, Effects of 1,25(OH)2D3, EB1089, and analog V on PTHrP production, PTHrP mRNA expression and cell growth in SCC 2/88. Anticancer Research. ,vol. 21, pp. 3355- 3363 ,(2001)